The clinical trials told one story. When patients stopped semaglutide in controlled research settings, they regained roughly ...

GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become ...

You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those drugs may have a negative ...

There is an increased risk of death for some people taking antidepressants or anti-anxiety medications, a new study from Queen’s University Belfast has suggested. The study led by researchers from the ...

These brain areas are also linked to impulsivity and emotional control in people with ADHD. By reducing food cravings and constant thoughts about eating, GLP⁠-1s may help some people feel more focused ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

For decades, experts have warned that older Americans are taking too many unnecessary drugs, often prescribed by multiple doctors, for dubious or unknown reasons. Researchers estimate that 25 percent ...